Abstract
S718 One-Year Comparative Effectiveness of Ustekinumab vs Tofacitinib for Ulcerative Colitis After Anti-Tumor Necrosis Factor Failure
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.14309/01.ajg.0000859512.98331.3f
Journal: American Journal of Gastroenterology | Publication Date: Oct 1, 2022 |
Citations: 1 |
S718 One-Year Comparative Effectiveness of Ustekinumab vs Tofacitinib for Ulcerative Colitis After Anti-Tumor Necrosis Factor Failure
Join us for a 30 min session where you can share your feedback and ask us any queries you have